August 17, 2017 12:31 PM ET

Biotechnology

Company Overview of Rigel Pharmaceuticals, Inc.

Executive Profile

Gary A. Lyons

AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 11 different industries.

See Board Relationships
66$157,148

Background

Mr. Gary A. Lyons served as the President and Chief Executive Officer of Neurocrine Biosciences, Inc. from February 1993 to January 2008. From 1983 to 1993, Mr. Lyons held various executive positions at Genentech Inc., including Vice President of Business Development, Vice President of Sales and Director of Sales & Marketing. He has over 35 years of management experience in the biotechnology and pharmaceutical industries. He served as a Director of Sales at American ...

Corporate Headquarters

1180 Veterans Boulevard
South San Francisco, California 94080

United States

Phone: 650-624-1100
Fax: 650-624-1101

Board Members Memberships

Director
1993-Present
Independent Director
1997-Present
Director
2005-Present
Chairman
2013-Present
Independent Director
2014-Present
Chairman

Education

BS
The University of New Hampshire, Durham
MBA
J.L. Kellogg School of Management, Northwestern University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$100,000
Total Calculated Compensation$157,148
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Amit D. Munshi President, CEO & Director
Arena Pharmaceuticals, Inc.
$397.8K
Paolo Pucci CEO & Director
ArQule, Inc.
$489.3K
Adam R. Craig M.D., Ph.D., M.B.A.President, CEO & Director
CTI BioPharma Corp.
--
Mark R. Baker J.D.Chief Executive Officer and Director
Progenics Pharmaceuticals, Inc.
$646.8K
Adelene Q. Perkins Chairman and Chief Executive Officer
Infinity Pharmaceuticals, Inc.
$668.8K
Compensation as of Fiscal Year 2016.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Rigel Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.